Forrester Total Economic Report Shows a 405% ROI on 6sense

July 15, 2019 | Sponsored

Calculating ROI has become a requirement for any corporate investment, across all business functions. Gone are the days when B2B marketers could attribute their spend to “branding.” Today, they’re being forced to provide concrete spend-to-revenue analysis to justify their investments in people, technologies – and really, every inch of their marketing efforts. So the pressure is on (and heavier than ever) for B2B marketers to make super smart decisions about where they put their money.

Spotlight

Chiesi Italia

Born in Parma in 1935 as a small workshop in the province, Chiesi Farmaceutici while maintaining strong roots in Italy, it is now an international company employing over 4,500 people in 25 countries and 4 continents, 560 of which are dedicated to research and development, and has a turnover of more than € 1.46 billion. In almost 80 years of history and three generations, the company has focused its activities on the research, development, manufacturing and commercialization of therapeutic solutions, developing successful drugs distributed in over 60 countries.

Other Infographics
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Pharmaceutical industry and medicine

Infographic | March 12, 2022

Pharmaceutical industry and medicine vector infographics with drugs, pills, bottles and packages, text blocks and charts all around

Read More
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More

Spotlight

Chiesi Italia

Born in Parma in 1935 as a small workshop in the province, Chiesi Farmaceutici while maintaining strong roots in Italy, it is now an international company employing over 4,500 people in 25 countries and 4 continents, 560 of which are dedicated to research and development, and has a turnover of more than € 1.46 billion. In almost 80 years of history and three generations, the company has focused its activities on the research, development, manufacturing and commercialization of therapeutic solutions, developing successful drugs distributed in over 60 countries.

Events